New patent expiration for Mayne Pharma drug DORYX
Annual Drug Patent Expirations for DORYX Doryx is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma […]
New patent expiration for Mayne Pharma drug DORYX Read Post »
Patent Expiration
New patent expiration for Mayne Pharma drug DORYX MPC
Annual Drug Patent Expirations for DORYX+MPC Doryx Mpc is a drug marketed by Mayne Pharma and is included in one
New patent expiration for Mayne Pharma drug DORYX MPC Read Post »
New patent expiration for Vanda Pharms drug HETLIOZ
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two
New patent expiration for Vanda Pharms drug HETLIOZ Read Post »
New patent expiration for Vanda Pharms drug HETLIOZ LQ
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in
New patent expiration for Vanda Pharms drug HETLIOZ LQ Read Post »
Drug Patent Expirations for the Week of December 4, 2022
VIIBRYD (vilazodone hydrochloride) Allergan Patent: 8,673,921 Expiration: Dec 5, 2022 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of December 4, 2022 Read Post »
New patent expiration for Allergan drug VIIBRYD
Annual Drug Patent Expirations for VIIBRYD Viibryd is a drug marketed by Allergan and is included in one NDA. It
New patent expiration for Sucampo Pharma drug AMITIZA
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one
New patent expiration for Sucampo Pharma drug AMITIZA Read Post »
Drug Patent Expirations for the Week of November 27, 2022
NEURONTIN (gabapentin) Viatris Patent: 7,256,216 Expiration: Nov 28, 2022 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of November 27, 2022 Read Post »
New patent expiration for Viatris drug NEURONTIN
Annual Drug Patent Expirations for NEURONTIN Neurontin is a drug marketed by Viatris and is included in three NDAs. It
New patent expiration for Viatris drug NEURONTIN Read Post »
